首页> 外文期刊>Open Journal of Regenerative Medicine >Combating 2019-nCoV Amidst the Pandemic Scare
【24h】

Combating 2019-nCoV Amidst the Pandemic Scare

机译:在大流行恐慌中,打击2019-NCOV

获取原文
       

摘要

2019-nCoV is the third consecutive coronavirus spread during the last 2 decades, but this time, unlike the previous two occasions, has achieved a pandemic proportion threatening widespread loss of human lives and a massive setback to the global economy. The situation warrants drastic measures in terms of preventing the spread of the virus and treating the virus-infected patients. The development of a new vaccine is a time-intensive option. Although efforts are underway to find possible pharmacological options, e.g., chloroquine, hydroxychloroquine, existing antiviral agents, etc., in the meanwhile we may work on the combinatorial interventional approach of combining drug therapy with passive immune therapy. It would be prudent to use a convalescent serum therapy approach with the serum from COVID-19 patients who have recovered from the infection.
机译:2019-NCOV是过去2年中连续第三次冠状病毒,但这一次与前两次不同,已经实现了大流行性比例威胁着危及人类生命的普遍存存和对全球经济的大规模挫折。情况是在预防病毒的扩散和治疗病毒感染患者方面的情况下持续措施。新疫苗的发展是一种时光的选择。尽管正在进行努力以找到可能的药理选择,例如氯喹,羟基喹啉,现有的抗病毒剂等,其同时,我们可以研究与被动免疫疗法结合药物治疗的组合介入方法。使用来自感染的Covid-19患者的血清血清患者是谨慎的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号